Intracranial hemorrhage devices market seen reaching $2.27B by 2030

The intracranial hemorrhage devices market is projected to grow from $1.79 billion in 2025 to $2.27 billion by 2030, driven by more brain injuries, more stroke cases and wider use of minimally invasive and AI-assisted care. North America led the market in 2025, while the report points to rising demand for real-time brain monitoring and better emergency stroke and trauma protocols.

Why it matters: - The market is tied to urgent care for brain bleeding, where faster diagnosis and treatment can reduce neurological damage and improve outcomes. - Growth in the market reflects rising demand for tools used in stroke, trauma and neurocritical care settings. - The report points to a $2.27 billion market by 2030, signaling continued investment in devices that support early intervention and real-time monitoring.

What happened: - The Business Research Company released a market report on intracranial hemorrhage devices on Aug. 12, 2026. - The report estimates the market will rise from $1.79 billion in 2025 to $1.88 billion in 2026. - The same report projects the market will reach $2.27 billion by 2030. - The report says North America was the largest regional market in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - A free sample of the report is available. - The full market report is also available.

The details: - Intracranial hemorrhage devices are used to diagnose, manage and treat bleeding within the skull. - The devices are used for subdural hematomas, epidural hematomas, subarachnoid hemorrhages and intracerebral hemorrhages. - The report says the devices help detect hemorrhages, monitor intracranial pressure and remove clots. - Historic growth is linked to traumatic brain injuries, higher stroke prevalence, expansion of neurocritical care units, better emergency medical services and newer diagnostic tools. - Future growth is expected to come from investment in neurotechnology, demand for real-time brain monitoring, more minimally invasive neurosurgery, broader use of AI-assisted imaging and earlier intervention. - The report flags advanced neuroimaging, intracranial pressure monitoring and improved emergency stroke and trauma care protocols as key trends. - The report says the 2026 edition adds market attractiveness scoring, total addressable market analysis, company scoring matrices, Excel forecasting dashboards, market hotspot infographics, and updated graphics and tables.

Between the lines: - The report frames neurological disease burden as a major growth driver for device demand. - In October 2025, the World Health Organization said fewer than one in three countries have national policies addressing neurological disorders. - The World Health Organization said neurological disorders cause more than 11 million deaths annually and affect more than 3 billion people worldwide. - That burden suggests hospitals and health systems may keep pushing for faster, more precise hemorrhage management tools. - North America’s lead likely reflects stronger healthcare infrastructure and deeper adoption of neurotechnology.

What's next: - The market is expected to keep expanding through 2030, though at a slightly slower pace than in the 2025-2026 period. - Vendors and care teams are likely to focus on imaging, pressure monitoring and minimally invasive procedures. - The report’s regional coverage suggests growth opportunities beyond North America, especially as emergency stroke and trauma systems mature.

The bottom line: - Intracranial hemorrhage devices are moving from a $1.79 billion market in 2025 toward a projected $2.27 billion by 2030, with clinical urgency and technology upgrades driving demand.